Abstract
Methods All procedures were performed in period between March 2011 and May 2013.In that period, 26 procedures performed in patients with severe aortic stenosis: of total, sixteen patents received Medtronic/CORE valve. Ten patients received Edwards/Sapien Aortic Bioprosthesis, of which, one implanted by transaortic way. The average age was 78.43 years. In premedication, all received midazolam 5 mg and clopidogrel 150 mg. All procedures were performed in general anesthesia using sevoflurane, small doses of i.v. fentanyl and rocuronium at the start of the procedure. Anesthesia maintained with sevoflurane up to the end of procedure. Rapid ventricular pacing achieved with transvenous temporary pacemaker. For evaluation of aortic valve, aortic root, left ventricular outflow tract pre and after procedure, in all patients transesophageal echocardiography (TEE) was used.
Highlights
The aim is to present the results of the two-years’ experience in the anesthetic management for percutaneous transcatheter aortic valve implantation (TAVI) procedures
All procedures were performed in period between March 2011 and May 2013.In that period, 26 procedures performed in patients with severe aortic stenosis: of total, sixteen patents received Medtronic/CORE valve
General anesthesia is optional because it provides better hemodynamic stability, it is more comfortable for the patient, and facilitates better conditions for precise and extremely important transesophageal echocardiography (TEE) estimations during procedure
Summary
The aim is to present the results of the two-years’ experience in the anesthetic management for percutaneous transcatheter aortic valve implantation (TAVI) procedures. Anesthesiology management for the transcatheter aortic valve implantation N Bradic1*, I Husedzinovic1, Z Sutlic2, D Unic2 From 23rd World Congress of the World Society of Cardio-Thoracic Surgeons Split, Croatia. Background The aim is to present the results of the two-years’ experience in the anesthetic management for percutaneous transcatheter aortic valve implantation (TAVI) procedures. Methods All procedures were performed in period between March 2011 and May 2013.In that period, 26 procedures performed in patients with severe aortic stenosis: of total, sixteen patents received Medtronic/CORE valve.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
